Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
2010 ◽
Vol 20
(2)
◽
pp. 119-130
◽
Keyword(s):